Sangart

Type
Business expansion
Country
Ireland
Region
Ireland; Southern; South-West
Location of affected unit(s)
Cork
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
250 jobs
Number of planned job creations
Job creation
Announcement Date
22 August 2011
Employment effect (start)
Foreseen end date

Description

American owned pharmaceutical manufacturer Sangart has announced 250 new jobs at a proposed new pharmaceutical manufacturing facility to be located in County Cork. It is understood that the new plant will function as Sangart's European headquarters, and the sales and manufacturing base in Europe for its MP4OX and MP4CO therapies.

Sources

  • 23 August 2011: The Irish Times

Citation

Eurofound (2011), Sangart, Business expansion in Ireland, factsheet number 72493, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/72493.